Open AccessVentricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients for Primary Prevention
Author(s) -
Luis NombelaFranco,
Cristina Mitroi,
Ignacio FernándezLozano,
Arturo GarcíaTouchard,
Jorge Toquero,
Víctor CastroUrda,
José Antonio Fernández-Díaz,
Elena Pérez-Pereira,
Paula Beltrán-Correas,
Javier Segovia,
Gerald S. Werner,
Javier Goicolea,
Alonso-Pulpón Luis
Publication year - 2012
Publication title -
circulation. arrhythmia and electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.684
H-Index - 102
eISSN - 1941-3149
pISSN - 1941-3084
DOI - 10.1161/circep.111.968008
Subject(s) - medicine , cardiology , interquartile range , implantable cardioverter defibrillator , myocardial infarction , sudden cardiac death , hazard ratio , coronary artery disease , ventricular tachycardia , ventricular fibrillation , confidence interval
An implantable cardioverter-defibrillator (ICD) is the therapy of choice for primary prevention in patients with ischemia who are at risk for sudden cardiac death (SCD). One third of patients with significant coronary disease have chronic total coronary occlusion (CTO), which is associated with long-term mortality in patients with previous myocardial infarction. However, the impact of CTO on the occurrence of ventricular arrhythmias and long-term mortality in ICD recipients remains unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom